e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.22
+0.60 (+1.04%)
Streaming Delayed Price
Updated: 12:05 PM EST, Feb 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,330,980
Open
58.91
Bid (Size)
58.21 (500)
Ask (Size)
58.23 (400)
Prev. Close
57.62
Today's Range
58.00 - 60.56
52wk Range
42.52 - 63.33
Shares Outstanding
2,222,113,553
Dividend Yield
4.33%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bristol Myers (BMY) Q4 2025 Earnings Transcript
↗
Today 9:45 EST
Bristol Myers (BMY) Q4 2025 Earnings Transcript
Via
The Motley Fool
Bristol Myers Squibb Co (NYSE:BMY) Beats Q4 2025 Earnings Estimates and Provides Strong 2026 Outlook
↗
Today 8:23 EST
Via
Chartmill
Performance
YTD
+8.9%
+8.9%
1 Month
+9.7%
+9.7%
3 Month
+25.3%
+25.3%
6 Month
+29.9%
+29.9%
1 Year
-1.5%
-1.5%
More News
Read More
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025
Today 8:14 EST
Via
StockStory
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
Today 6:59 EST
From
Bristol Myers Squibb
Via
Business Wire
Bristol-Myers Squibb Co (NYSE:BMY) Shows Strong Technical Setup for Potential Breakout
↗
January 28, 2026
Via
Chartmill
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock With a Path to Growth
↗
January 17, 2026
Via
Chartmill
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi
February 04, 2026
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Q4 Earnings Preview: Profits Under Pressure Even As Wall Street Bets On 2026 Pipeline
↗
February 04, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Intellectual Property
Workforce
Bristol-Myers Squibb Earnings: What To Look For From BMY
February 03, 2026
Via
StockStory
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
February 03, 2026
From
Bristol Myers Squibb
Via
Business Wire
The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
February 02, 2026
Via
MarketMinute
Topics
Economy
Government
Intellectual Property
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via
MarketMinute
Topics
ETFs
Government
Initial Public Offering
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year
↗
January 30, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
World Trade
3 Unpopular Stocks That Concern Us
January 28, 2026
Via
StockStory
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
January 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
2 Under-the-Radar Biotech Stocks Set to Boom in 2026
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
World Trade
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
↗
January 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
January 23, 2026
Via
The Motley Fool
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
The Best Stocks to Invest $1,000 in Right Now
↗
January 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
2 Dividend Stocks to Buy and Hold For 10 Years
↗
January 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Buffett Stocks to Load Up On—And 1 to Ditch
↗
January 19, 2026
Via
MarketBeat
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 58.22
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 02/05/26 12:05 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 129.37B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 129B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert